| scholarly article | Q13442814 |
| P50 | author | Zahra Aryan | Q38590487 |
| Hossein Esmaeilzadeh | Q41608383 | ||
| P2093 | author name string | Mohammad Nabavi | |
| Ali Akbar Amirzargar | |||
| P2860 | cites work | Increased level of interleukin-13, but not interleukin-4 and interferon-γ in chronic rhinosinusitis with nasal polyps | Q45718442 |
| Long-term treatment with aspirin desensitization: a prospective clinical trial comparing 100 and 300 mg aspirin daily | Q46432280 | ||
| The HLA allele marker for differentiating ASA hypersensitivity phenotypes | Q47946726 | ||
| Psychometric validity of the 22-item Sinonasal Outcome Test | Q49013965 | ||
| Aspirin desensitization in patients with aspirin-induced and aspirin-tolerant asthma: a double-blind study. | Q51091863 | ||
| Aspirin 300 mg/day is effective for treating aspirin-exacerbated respiratory disease. | Q51194137 | ||
| HLA-DRB and HLA-DQ genetic variability in patients with aspirin-exacerbated respiratory disease. | Q51631290 | ||
| Aspirin hypersensitivity in patients with chronic rhinosinusitis and nasal polyposis: frequency and contributing factors. | Q51713446 | ||
| Genome-wide association study of aspirin-exacerbated respiratory disease in a Korean population. | Q53352652 | ||
| Association of HLA-DR3 and HLA-DR4 with Sinonasal Polyposis in Mexican Mestizos | Q57620381 | ||
| Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes | Q24633568 | ||
| Human leukocyte antigen class II allele frequencies and haplotype association in Iranian normal population | Q28204756 | ||
| The HLA-DPB1*0301 marker might predict the requirement for leukotriene receptor antagonist in patients with aspirin-intolerant asthma | Q28213777 | ||
| Selection of aspirin dosages for aspirin desensitization treatment in patients with aspirin-exacerbated respiratory disease | Q28213966 | ||
| Mechanisms of aspirin-intolerant asthma: identifying inflammatory pathways in the pathogenesis of asthma | Q28302199 | ||
| HLA-DQ strikes again: genome-wide association study further confirms HLA-DQ in the diagnosis of asthma among adults. | Q29417102 | ||
| Alcohol-induced respiratory symptoms are common in patients with aspirin exacerbated respiratory disease | Q33598927 | ||
| Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: A meta-analysis of the literature | Q34441715 | ||
| Global strategy for asthma management and prevention: GINA executive summary. | Q34731997 | ||
| MHC class II expression in human basophils: induction and lack of functional significance | Q35069773 | ||
| Pharmacogenetics of aspirin-intolerant asthma | Q37043508 | ||
| Aspirin-intolerant asthma: a comprehensive review of biomarkers and pathophysiology. | Q38062847 | ||
| Allergen-specific immunotherapy in asthmatic children: from the basis to clinical applications | Q38113269 | ||
| Evidence-based approach to aspirin desensitization in aspirin-exacerbated respiratory disease | Q38173911 | ||
| A new era of targeting the ancient gatekeepers of the immune system: toll-like agonists in the treatment of allergic rhinitis and asthma | Q38213946 | ||
| Use of intranasal ketorolac and modified oral aspirin challenge for desensitization of aspirin-exacerbated respiratory disease | Q42950579 | ||
| A highly sensitive and specific genetic marker to diagnose aspirin-exacerbated respiratory disease using a genome-wide association study | Q43561634 | ||
| Low-dose aspirin desensitization in individuals with aspirin-exacerbated respiratory disease | Q43881393 | ||
| Predicting outcomes of oral aspirin challenges in patients with asthma, nasal polyps, and chronic sinusitis | Q44432091 | ||
| P433 | issue | 5 | |
| P921 | main subject | desensitization | Q2700499 |
| aspirin | Q18216 | ||
| P304 | page(s) | 511-518 | |
| P577 | publication date | 2015-08-26 | |
| P1433 | published in | Expert Review of Respiratory Medicine | Q15754583 |
| P1476 | title | Pharmacogenetic tests to predict the efficacy of aspirin desensitization in patients with aspirin-exacerbated respiratory diseases; HLA-DQB302. | |
| P478 | volume | 9 |
| Q55477938 | Clinical and Immunological Efficacy of Aspirin Desensitization in Nasal Polyp Patients with Aspirin-Exacerbated Respiratory Disease. |
| Q64236304 | Epidemiology of Severe Cutaneous Adverse Drug Reaction and Its HLA Association among Pediatrics |
| Q47649225 | Physiopathology and genetics in aspirin-exacerbated respiratory disease |
Search more.